Literature DB >> 19786535

Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease.

Danica J Schulte1, Atilla Yilmaz, Kenichi Shimada, Michael C Fishbein, Emily L Lowe, Shuang Chen, Michelle Wong, Terence M Doherty, Thomas Lehman, Timothy R Crother, Rosalinda Sorrentino, Moshe Arditi.   

Abstract

Kawasaki disease (KD) is the most common cause of acquired cardiac disease and acute vasculitis in children in the developed world. Injection of a cell wall extract isolated from Lactobacillus casei (LCCWE) into mice causes a focal coronary arteritis that histopathologically mimics the coronary lesions observed in KD patients. In this study we used this model to investigate the participation of T cells, B cells, and dendritic cells (DC) in the development of coronary arteritis. RAG1(-/-), B cell(null), and wild-type (WT) mice were injected with a single dose of LCCWE (500 microg/mouse i.p.). None of the RAG1(-/-) mice developed coronary arteritis, whereas 70% of WT and 100% of B cell(null) mice developed coronary lesions, indicating that T cells were required for lesion formation. When splenocytes isolated from LCCWE-treated mice were restimulated with LCCWE, we observed significant IFN-gamma secretion in WT but not in RAG1(-/-) mice. Immunohistochemical staining showed F4/80(+) macrophages, activated MIDC-8(+) myeloid DCs (mDC), plasmacytoid DCs, and colocalization of CD3(+) T cells with mDCs in coronary artery lesions, suggesting an Ag-driven process. T cells but not B cells are required for LCCWE-induced coronary arteritis. Similar to human lesions, the coronary lesions contain macrophages, activated mDCs, and plaslmacytoid DCs all in close proximity to T cells, further strengthening the relevance of this mouse model to the immunopathology of coronary disease in KD. These studies are consistent with the interpretation that macrophages and DCs may collaborate with T cells in the pathological mechanisms of coronary arteritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786535      PMCID: PMC3031986          DOI: 10.4049/jimmunol.0901395

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

2.  Dendritic cells of the mouse recognized by two monoclonal antibodies.

Authors:  M Breel; R E Mebius; G Kraal
Journal:  Eur J Immunol       Date:  1987-11       Impact factor: 5.532

3.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

4.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

5.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

6.  Variable expression of Lactobacillus casei cell wall-induced coronary arteritis: an animal model of Kawasaki's disease in selected inbred mouse strains.

Authors:  T J Lehman; R Warren; D Gietl; V Mahnovski; M Prescott
Journal:  Clin Immunol Immunopathol       Date:  1988-07

7.  Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension.

Authors:  T J Lehman; S M Walker; V Mahnovski; D McCurdy
Journal:  Arthritis Rheum       Date:  1985-06

Review 8.  Animal models of vasculitis. Lessons we can learn to improve our understanding of Kawasaki disease.

Authors:  T J Lehman; V Mahnovski
Journal:  Rheum Dis Clin North Am       Date:  1988-08       Impact factor: 2.670

9.  Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease.

Authors:  M Terai; Y Kohno; M Namba; T Umemiya; K Niwa; H Nakajima; A Mikata
Journal:  Hum Pathol       Date:  1990-02       Impact factor: 3.466

10.  High-dose intravenous gammaglobulin for Kawasaki disease.

Authors:  K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

View more
  28 in total

Review 1.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

2.  Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease.

Authors:  Youngho Lee; Danica J Schulte; Kenichi Shimada; Shuang Chen; Timothy R Crother; Norika Chiba; Michael C Fishbein; Thomas J A Lehman; Moshe Arditi
Journal:  Circulation       Date:  2012-02-23       Impact factor: 29.690

3.  IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β.

Authors:  Youngho Lee; Daiko Wakita; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Ganghua Huang; Thomas J A Lehman; Michael C Fishbein; Hal M Hoffman; Timothy R Crother; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

Review 4.  Aortic Aneurysms.

Authors:  Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06       Impact factor: 8.311

Review 5.  Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Authors:  Jane C Burns; Isabelle Koné-Paut; Taco Kuijpers; Chisato Shimizu; Adriana Tremoulet; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

6.  Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).

Authors:  Adriana H Tremoulet; Sonia Jain; Susan Kim; Jane Newburger; Moshe Arditi; Alessandra Franco; Brookie Best; Jane C Burns
Journal:  Contemp Clin Trials       Date:  2016-04-11       Impact factor: 2.226

7.  Inhibition of transforming growth factor β worsens elastin degradation in a murine model of Kawasaki disease.

Authors:  Cristina M Alvira; Christophe Guignabert; Yu-Mee Kim; Chihhsin Chen; Lingli Wang; Trang T Duong; Rae S M Yeung; Dean Y Li; Marlene Rabinovitch
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

8.  CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease.

Authors:  Magali Noval Rivas; Youngho Lee; Daiko Wakita; Norika Chiba; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Michael C Fishbein; Thomas J A Lehman; Timothy R Crother; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

9.  Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm.

Authors:  Daiko Wakita; Yosuke Kurashima; Timothy R Crother; Magali Noval Rivas; Youngho Lee; Shuang Chen; Wen Fury; Yu Bai; Shawn Wagner; Debiao Li; Thomas Lehman; Michael C Fishbein; Hal M Hoffman; Prediman K Shah; Kenichi Shimada; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-03       Impact factor: 8.311

Review 10.  Adjunctive therapies in Kawasaki disease.

Authors:  Adriana H Tremoulet
Journal:  Int J Rheum Dis       Date:  2017-10-27       Impact factor: 2.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.